Cetera Investment Advisers Acquires 896 Shares of SPDR S&P China ETF $GXC

Cetera Investment Advisers boosted its holdings in shares of SPDR S&P China ETF (NYSEARCA:GXC) by 32.4% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,662 shares of the company’s stock after acquiring an additional 896 shares during the quarter. Cetera Investment Advisers owned approximately 0.07% of SPDR S&P China ETF worth $315,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Wealthcare Advisory Partners LLC bought a new position in shares of SPDR S&P China ETF in the first quarter valued at approximately $3,407,000. Ameriprise Financial Inc. bought a new position in shares of SPDR S&P China ETF in the fourth quarter valued at approximately $1,853,000. Ibex Wealth Advisors bought a new position in shares of SPDR S&P China ETF in the first quarter valued at approximately $2,077,000. Yoffe Investment Management LLC bought a new position in shares of SPDR S&P China ETF in the fourth quarter valued at approximately $692,000. Finally, Wealthfront Advisers LLC raised its position in shares of SPDR S&P China ETF by 164.4% in the first quarter. Wealthfront Advisers LLC now owns 13,000 shares of the company’s stock valued at $1,118,000 after purchasing an additional 8,083 shares during the period.

SPDR S&P China ETF Stock Down 0.7%

NYSEARCA:GXC opened at $95.35 on Wednesday. SPDR S&P China ETF has a 12 month low of $64.69 and a 12 month high of $97.17. The firm has a market cap of $467.22 million, a price-to-earnings ratio of 12.97 and a beta of 0.50. The company’s 50 day moving average is $90.24 and its 200-day moving average is $86.21.

SPDR S&P China ETF Company Profile

SPDR S&P China ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI China Index (the Index). The Index is a market capitalization-weighted index that defines and measures the investable universe of publicly traded companies domiciled in China, but legally available to foreign investors.